GlassScriptPhysician profile
George M Davis
NPI 1285664557
$3,421.72
in general payments reported to CMS, 2019-2025
8 companies · $547 in 2025
The $547 reported for 2025 was more than what 93% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $163 · 2021: $351 · 2022: $393 · 2023: $597 · 2024: $418 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,284.96 | 2023-2025 | Botox |
| Allergan, INC. | $959.50 | 2019-2022 | |
| Apyx Medical Corporation | $838.00 | 2019-2020 | |
| Revance Therapeutics, INC. | $150.89 | 2024-2025 | Daxxify |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2025 | Airsupra |
| Galderma Laboratories, L.P. | $30.25 | 2020-2022 | |
| Hologic Sales and Service, LLC | $20.44 | 2022 | |
| Pfizer INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.